JCPenney Gets $2.25...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$97.96 0.23 | 0.24%
05/23/13 - 04:00 PM ET
Latest Dividend:0.05
Latest Dividend Yield:0.20%
Dividend Ex-Date:05/21/13
Price Earnings Ratio:26.42
Price Earnings Comparisons:
| AGN | Sector Avg. | S&P 500 |
|---|---|---|
| 26.42 | 34.20 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -6.92 | 8.83 | 69.75 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 7.10 | 0.29 | 0.09 |
| Net Income | 0.77 | 0.21 | |
| EPS | 18.90 | 0.78 | 0.21 |
Earnings for AGN:
| EBITDA | 1.89B |
| REVENUE | 5.81B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.20 | $1.21 | $4.75 | $5.48 |
| Number of Analysts | 15 | 15 | 19 | 18 |
| High Estimate | $1.25 | $1.26 | $4.88 | $5.84 |
| Low Estimate | $1.18 | $1.18 | $4.71 | $5.28 |
| Prior Year | $1.07 | $1.06 | $4.14 | $4.75 |
| Growth Rate (Year over Year) | 12.09% | 14.53% | 14.80% | 15.30% |
Portfolios with AGN
- Portfolio NameUser Type
- ProRay Dalio - Bridgewater Ass...
- ContributorHigh Volume Technicals for ...
- ContributorTechnical Setups for the We...
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
Latest AGN Headlines from TheStreet
- Cramer Talks Abbott & Glaxo
04.17.13 | 03:04 pm - Allergan Reaches New 52-Week High (AGN) 04.11.13 | 10:04 am
- Allergan Inc. Stock Buy Recommendation Reiterated (AGN) 04.11.13 | 10:04 am
- Allergan Becomes #172 Most Shorted S&P 500 Component, Replacing Emerson Electric 04.10.13 | 03:04 pm
- Allergan Reaches New 52-Week High (AGN) 04.02.13 | 11:04 am
- Allergan Inc. Stock Buy Recommendation Reiterated (AGN) 04.01.13 | 10:04 am
- Cramer's 'Mad Money' Recap: Shift Your Perspective 03.27.13 | 08:03 pm
- Allergan Reaches New 52-Week High (AGN) 03.26.13 | 10:03 am
- Allergan Inc. Stock Buy Recommendation Reiterated (AGN) 03.19.13 | 10:03 am
- 5 Stocks Pushing The Health Care Sector Higher 03.11.13 | 01:03 pm
Press Releases for AGN
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants - Business Wire 02.20.13 | 06:02 pm
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Reports Fourth Quarter 2012 Operating Results - Business Wire 02.05.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- MAP Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Allergan, Inc. - PR Newswire 01.23.13 | 11:01 am
- Allergan, Inc. To Acquire MAP Pharmaceuticals, Inc. - Business Wire 01.22.13 | 08:01 pm
- BOTOX(R) (onabotulinumtoxinA) Receives U.S. Food And Drug Administration Approval For The Treatment Of Overactive Bladder For Adults Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication - Business Wire 01.18.13 | 05:01 pm
- Allergan Announces Quarterly Conference Call - Business Wire 01.07.13 | 05:01 pm
Partner Headlines for AGN
- Apache, Windstream and Other Stocks Insiders Are Buying - Benzinga 04.06.13 | 12:04 pm
- Johnson & Johnson's Quest to Knock Botox off the Pedestal - Benzinga 03.22.13 | 02:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for February 26, 2013 - NASDAQ 02.22.13 | 02:02 pm
- Why I Sold Allergan - Seeking Alpha 02.01.13 | 07:02 pm
- How To Play The Cosmeceutical Market - Seeking Alpha 12.25.12 | 09:12 am
- Buy MAP Pharmaceutical For 70% Upside - Seeking Alpha 11.26.12 | 09:11 am
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for November 19, 2012 - NASDAQ 11.15.12 | 02:11 pm
